H. Mulec

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Renal protective effect of enalapril in diabetic nephropathy.

S Björck, H. Mulec, Svend Aage Johnsen et al. · BMJ · 1992 · 437 citations · Full text

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

S Björck, G. Nyberg, H. Mulec et al. · BMJ · 1986 · 412 citations · Full text

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

Ola Samuelsson, H. Mulec, Carolyn Knight‐Gibson et al. · Nephrology Dialysis Transplantation · 1997 · 233 citations · Full text

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

S Björck, H. Mulec, Svend Aage Johnsen et al. · BMJ · 1990 · 131 citations · Full text